Cargando…

Celiac disease in the COVID-19 pandemic

BACKGROUND: The COVID-19 pandemic has had an impact on global health. DESIGN: The impact of the COVID-19 pandemic on patients with coeliac disease was assessed in the present review. RESULTS: The incidence of coeliac disease and the problems associated with coeliac disease increased during the COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Samasca, Gabriel, Lerner, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406545/
https://www.ncbi.nlm.nih.gov/pubmed/34485888
http://dx.doi.org/10.1016/j.jtauto.2021.100120
_version_ 1783746524170158080
author Samasca, Gabriel
Lerner, Aaron
author_facet Samasca, Gabriel
Lerner, Aaron
author_sort Samasca, Gabriel
collection PubMed
description BACKGROUND: The COVID-19 pandemic has had an impact on global health. DESIGN: The impact of the COVID-19 pandemic on patients with coeliac disease was assessed in the present review. RESULTS: The incidence of coeliac disease and the problems associated with coeliac disease increased during the COVID-19 pandemic. Adherence to the diet is crucial for the patient's health and quality of life since the only approved therapy for coeliac disease is a gluten withdrawal. CONCLUSIONS: A gluten-free diet should be promoted by the therapeutic team and implemented among these categories of patients.
format Online
Article
Text
id pubmed-8406545
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84065452021-08-31 Celiac disease in the COVID-19 pandemic Samasca, Gabriel Lerner, Aaron J Transl Autoimmun VSI: Autoimmune tautology, Infection and autoimmunity BACKGROUND: The COVID-19 pandemic has had an impact on global health. DESIGN: The impact of the COVID-19 pandemic on patients with coeliac disease was assessed in the present review. RESULTS: The incidence of coeliac disease and the problems associated with coeliac disease increased during the COVID-19 pandemic. Adherence to the diet is crucial for the patient's health and quality of life since the only approved therapy for coeliac disease is a gluten withdrawal. CONCLUSIONS: A gluten-free diet should be promoted by the therapeutic team and implemented among these categories of patients. Elsevier 2021-08-31 /pmc/articles/PMC8406545/ /pubmed/34485888 http://dx.doi.org/10.1016/j.jtauto.2021.100120 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle VSI: Autoimmune tautology, Infection and autoimmunity
Samasca, Gabriel
Lerner, Aaron
Celiac disease in the COVID-19 pandemic
title Celiac disease in the COVID-19 pandemic
title_full Celiac disease in the COVID-19 pandemic
title_fullStr Celiac disease in the COVID-19 pandemic
title_full_unstemmed Celiac disease in the COVID-19 pandemic
title_short Celiac disease in the COVID-19 pandemic
title_sort celiac disease in the covid-19 pandemic
topic VSI: Autoimmune tautology, Infection and autoimmunity
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406545/
https://www.ncbi.nlm.nih.gov/pubmed/34485888
http://dx.doi.org/10.1016/j.jtauto.2021.100120
work_keys_str_mv AT samascagabriel celiacdiseaseinthecovid19pandemic
AT lerneraaron celiacdiseaseinthecovid19pandemic